Abbvie Inc (NYSE:ABBV)
| 138.14 Delayed Data As of Jun 09 |  +0.50 / +0.36%Today’s Change | 131.10 Today|||52-Week Range 168.11 | -14.52% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 137.64 |
| Today’s open | 137.78 |
| Day’s range | 137.07 - 139.19 |
| Volume | 4,359,676 |
| Average volume (3 months) | 5,942,024 |
| Market cap | $241.5B |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +2.68% |
| Earnings growth (this year) | -20.07% |
| Earnings growth (next 5 years) | -0.50% |
| Revenue growth (last year) | +3.30% |
| P/E ratio | 32.5 |
| Price/Sales | 4.95 |
| Price/Book | 14.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.19 | -0.26% |
| PFEPfizer | -0.12 | -0.31% |
| NVONovo Nordisk | -1.38 | -0.87% |
| NVSNovartis | +0.28 | +0.28% |
Data as of 4:00pm ET, 06/09/2023
Financials
| Next reporting date | July 28, 2023 |
| EPS forecast (this quarter) | $2.92 |
| Annual revenue (last year) | $58.1B |
| Annual profit (last year) | $11.8B |
| Net profit margin | 20.29% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
